• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors.

作者信息

Zwiers Laura C, Ong David S Y, Grobbee Diederick E

机构信息

Julius Clinical, Zeist, The Netherlands.

Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

出版信息

Glob Heart. 2023 Jul 31;18(1):39. doi: 10.5334/gh.1252. eCollection 2023.

DOI:10.5334/gh.1252
PMID:38533475
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10964799/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cda/10964799/59b868076d29/gh-18-1-1252-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cda/10964799/59b868076d29/gh-18-1-1252-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cda/10964799/59b868076d29/gh-18-1-1252-g1.jpg

相似文献

1
COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors.新型冠状病毒肺炎疫苗诱导的心肌炎和心包炎：迈向危险因素的识别
Glob Heart. 2023 Jul 31;18(1):39. doi: 10.5334/gh.1252. eCollection 2023.
2
Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.新型冠状病毒肺炎（COVID-19）疫苗接种后心肌炎和心包炎的发生率、危险因素、自然史和假设发病机制：基于实时证据的综合分析和综述。
BMJ. 2022 Jul 13;378:e069445. doi: 10.1136/bmj-2021-069445.
3
A narrative review of vaccine pharmacovigilance during mass vaccination campaigns: Focus on myocarditis and pericarditis after COVID-19 mRNA vaccination.大规模疫苗接种运动期间疫苗药物警戒的叙述性综述：关注 COVID-19 mRNA 疫苗接种后的心肌炎和心包炎。
Br J Clin Pharmacol. 2023 Mar;89(3):967-981. doi: 10.1111/bcp.15625. Epub 2022 Dec 26.
4
Benefit-risk assessment for the Novavax COVID-19 vaccine (NVX-CoV2373).Novavax COVID-19 疫苗（NVX-CoV2373）的获益-风险评估。
Vaccine. 2024 Apr 2;42(9):2161-2165. doi: 10.1016/j.vaccine.2024.03.036. Epub 2024 Mar 16.
5
Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines.mRNA COVID-19 疫苗接种后的心肌炎和/或心包炎风险：BNT162b2 和 mRNA-1273 疫苗的加拿大头对头比较。
Vaccine. 2022 Jul 30;40(32):4663-4671. doi: 10.1016/j.vaccine.2022.05.048. Epub 2022 May 25.
6
Booster dose of COVID-19 mRNA vaccine does not increase risks of myocarditis and pericarditis compared with primary vaccination: New insights from the vaccine adverse event reporting system.与基础免疫相比，COVID-19 mRNA 疫苗加强针不会增加心肌炎和心包炎的风险：疫苗不良事件报告系统的新见解。
Front Immunol. 2022 Sep 12;13:938322. doi: 10.3389/fimmu.2022.938322. eCollection 2022.
7
Comparative safety profile of bivalent and original COVID-19 mRNA vaccines regarding myocarditis/pericarditis: A pharmacovigilance study.二价和原始 COVID-19 mRNA 疫苗在心肌炎/心包炎方面的比较安全性概况：一项药物警戒研究。
Int Immunopharmacol. 2024 May 30;133:112022. doi: 10.1016/j.intimp.2024.112022. Epub 2024 Apr 13.
8
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.意大利 12 至 39 岁人群接种 COVID-19 mRNA 疫苗后的心肌炎和心包炎上市后主动监测：多数据库、自身对照病例系列研究。
PLoS Med. 2022 Jul 28;19(7):e1004056. doi: 10.1371/journal.pmed.1004056. eCollection 2022 Jul.
9
A Systematic Review and Meta-analysis of the Association Between SARS-CoV-2 Vaccination and Myocarditis or Pericarditis.SARS-CoV-2 疫苗接种与心肌炎或心包炎相关性的系统评价和荟萃分析。
Am J Prev Med. 2023 Feb;64(2):275-284. doi: 10.1016/j.amepre.2022.09.002. Epub 2022 Sep 26.
10
Comparative assessment of myocarditis and pericarditis reporting rates related to mRNA COVID-19 vaccines in Europe and the United States.比较评估欧洲和美国与 mRNA COVID-19 疫苗相关的心肌炎和心包炎报告率。
Expert Rev Vaccines. 2022 Nov;21(11):1691-1696. doi: 10.1080/14760584.2022.2100765. Epub 2022 Jul 25.

引用本文的文献

1
Incidence and Nature of Short-Term Adverse Events following COVID-19 Second Boosters: Insights from Taiwan's Universal Vaccination Strategy.新冠病毒二次加强针接种后短期不良事件的发生率及性质：来自台湾全民疫苗接种策略的见解
Vaccines (Basel). 2024 Jan 31;12(2):149. doi: 10.3390/vaccines12020149.
2
Correction: COVID-19 Vaccine-Induced Myocarditis and Pericarditis: Towards Identification of Risk Factors.更正：COVID-19 疫苗诱导的心肌炎和心包炎：寻找危险因素。
Glob Heart. 2024 Jan 8;19(1):1. doi: 10.5334/gh.1276. eCollection 2024.

本文引用的文献

1
Myocarditis/pericarditis following vaccination with BNT162b2, CoronaVac, and ChAdOx1 among adolescent and adult in Malaysia.马来西亚青少年和成年人接种BNT162b2、科兴疫苗（CoronaVac）和牛津/阿斯利康疫苗（ChAdOx1）后发生的心肌炎/心包炎
Vaccine X. 2023 Aug;14:100303. doi: 10.1016/j.jvacx.2023.100303. Epub 2023 Apr 15.
2
Myocarditis.心肌炎
N Engl J Med. 2022 Oct 20;387(16):1488-1500. doi: 10.1056/NEJMra2114478.
3
Outcomes at least 90 days since onset of myocarditis after mRNA COVID-19 vaccination in adolescents and young adults in the USA: a follow-up surveillance study.
美国青少年和年轻成年人接种 mRNA COVID-19 疫苗后至少 90 天的心肌炎结局：一项随访监测研究。
Lancet Child Adolesc Health. 2022 Nov;6(11):788-798. doi: 10.1016/S2352-4642(22)00244-9. Epub 2022 Sep 22.
4
Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.新型冠状病毒肺炎（COVID-19）疫苗接种后心肌炎和心包炎的发生率、危险因素、自然史和假设发病机制：基于实时证据的综合分析和综述。
BMJ. 2022 Jul 13;378:e069445. doi: 10.1136/bmj-2021-069445.
5
Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases.美国 COVID-19 mRNA 疫苗接种后的心肌炎和心包炎风险：索赔数据库中的队列研究。
Lancet. 2022 Jun 11;399(10342):2191-2199. doi: 10.1016/S0140-6736(22)00791-7.
6
Global reports of myocarditis following COVID-19 vaccination: A systematic review and meta-analysis.全球 COVID-19 疫苗接种后心肌炎报告：系统评价和荟萃分析。
Diabetes Metab Syndr. 2022 Jun;16(6):102513. doi: 10.1016/j.dsx.2022.102513. Epub 2022 May 27.
7
Reports of myocarditis and pericarditis following mRNA COVID-19 vaccination: a systematic review of spontaneously reported data from the UK, Europe and the USA and of the scientific literature.报告显示，接种 mRNA COVID-19 疫苗后可能引发心肌炎和心包炎：对来自英国、欧洲和美国的自发报告数据以及科学文献的系统评价。
BMJ Open. 2022 May 25;12(5):e059223. doi: 10.1136/bmjopen-2021-059223.
8
SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents.SARS-CoV-2 疫苗接种与 2300 万居民的北欧队列研究中的心肌炎。
JAMA Cardiol. 2022 Jun 1;7(6):600-612. doi: 10.1001/jamacardio.2022.0583.
9
Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute Myocarditis.COVID-19 相关心肌炎的患病率、特征和结局。
Circulation. 2022 Apr 12;145(15):1123-1139. doi: 10.1161/CIRCULATIONAHA.121.056817. Epub 2022 Apr 11.
10
COVID-19 and myocarditis: a review of literature.新型冠状病毒肺炎与心肌炎：文献综述
Egypt Heart J. 2022 Apr 5;74(1):23. doi: 10.1186/s43044-022-00260-2.